Beta to Alpha

Beta to Alpha

Share this post

Beta to Alpha
Beta to Alpha
Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)

Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)

Let's delve deeper.

Saket Mehrotra's avatar
Saket Mehrotra
Sep 17, 2020
∙ Paid
3

Share this post

Beta to Alpha
Beta to Alpha
Will Covid-19 separate the wheat from the chaff in the Indian pharma industry? (Part 2 of 2)
2
Share

If we compare the Operating Profit margins of most of the pharmaceutical companies in India (domestic as well as MNC players) they are more or less in the 19-23% bracket. But when it comes to ROCE, the MNC pack is clearly the outperformer. Let’s have a look here.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Saket Mehrotra
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share